PDS Biotechnology Corporation (PDSB) vs Sangamo Therapeutics, Inc. (SGMOQ)
PDS Biotechnology Corporation and Sangamo Therapeutics, Inc. are both Biotechnology companies. PDS Biotechnology Corporation and Sangamo Therapeutics, Inc. are of similar size ($44.2M and $41.9M). PDS Biotechnology Corporation has the higher net margin (0.00% vs −356.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PDS Biotechnology Corporation leads on 8 and Sangamo Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | PDSB | SGMOQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (357.55%) | 0.00% |
| Net margin | 0.00% | (356.89%) | 0.00% |
| Free cash flow margin | 0.00% | (261.76%) | 0.00% |
| Return on equity | (543.97%) | 1,755.72% | (57.72%) |
| Return on assets | (136.65%) | (168.79%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack